STAAR SURGICAL CO

For the period ended Jan 2, 2026. Filed Mar 3, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2026 · Filed Mar 3, 2026

STAA$23.87-2.8%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Cover page

PART I

Item 1. Business (no text here)

ITEM 1. Business

Item 1A. Risk Factors (no text here)

ITEM 1A. Risk Factors

Item 1B. Unresolved Staff Comments (no text here)

ITEM 1B. Unresolved Staff Comments

Item 1C. Cybersecurity (no text here)

ITEM 1C. Cybersecurity

Item 2. Properties (no text here)

ITEM 2. Properties

Item 3. Legal Proceedings (no text here)

ITEM 3. Legal Proceedings

Item 4. Mine Safety Disclosures (no text here)

ITEM 4. Mine Safety Disclosures

PART II

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities (no text here)

ITEM 5. Market for Registrant’s Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities Unregistered Sales of Equity Securities and Use of Proceeds

Item 6. [Reserved] (no text here)

ITEM 6. [Reserved] (no text here)

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations (no text here)

ITEM 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Item 7A. Quantitative and Qualitative Disclosures About Market Risk (no text here)

ITEM 7A. Quantitative and Qualitative Disclosures About Market Risk ITEM 8. Financial Statements and Supplementary Data

Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure (no text here)

ITEM 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

Item 9A. Controls and Procedures (no text here)

ITEM 9A. Controls and Procedures

Item 9B. Other Information (no text here)

ITEM 9B. Other Information

Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections (no text here)

ITEM 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

PART III

PART III Item 10. Directors, Executive Officers, and Corporate Governance Item 11. Executive Compensation Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters Item 13. Certain Relationships and Related Transactions, and Director Independence Item 14. Principal Accounting Fees and Services

PART IV

Item 15. Exhibits and Financial Statement Schedules (no text here)

ITEM 15. Exhibits and Financial Statement Schedules

Item 16. Form 10-K Summary (no text here)

ITEM 16. Form 10-K Summary SIGNATURES Report of Independent Registered Public Accounting Firm Consolidated Balance Sheets Consolidated Statements of Operations Consolidated Statements of Comprehensive Income (Loss)Consolidated Statements of Stockholders’ Equity Item 8. Consolidated Statements of Cash Flows Notes to Consolidated Financial Statements II. Schedule II — Valuation and Qualifying Accounts and Reserves

Unregistered Sales of Equity Securities and Use of Proceeds

The following table summarizes the Company’s share repurchase activity for the three months ended January 2, 2026, on a monthly basis:

Period · Total Number of Shares (or Units) Purchased · Average Price Paid per Share (or Unit) · Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs · Maximum Number (or Approximate Dollar Value) of Shares that may yet to be Purchased Under the Plans or Programs (in thousands)(1)
September 27 - October 24, 2025	—	$—		—	$23,539
October 25 - November 21, 2025	—	—		—	23,539
November 22 - January 2, 2026	—	—		—	23,539
Total	—		—

(1)

On May 16, 2025, the Company announced that its Board of Directors authorized a share repurchase program under which the Company may repurchase up to $30 million of its outstanding common stock. During the three months ended January 2, 2026 the Company did not purchase shares. As of January 2, 2026, approximately $23.5 million remained available for repurchases pursuant to our share repurchase program. Under the share repurchase program, the Company may repurchase shares in the open market, through privately negotiated transactions, by entering into structured repurchase agreements with third parties, by making block purchases, and/or pursuant to Rule 10b5-1 trading plans. The timing, manner, price, and amount of any repurchases under the program will be determined by the Company in its discretion, subject to market conditions, legal requirements, and other considerations. The Company is not obligated to repurchase any specific number of shares, and the program may be modified, suspended, or discontinued at any time, without prior notice.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.